6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Sofgen Pharma S.A.
Filed: November 23, 2021
Period of Report: November 23, 2021
Accession Number: 0001213900-21-061624

View Document ↗ View on SEC.gov ↗